Awareness of and willingness to use digital therapeutics among orthopedic rehabilitation medical staff: a questionnaire survey

doi:10.3877/cma.j.issn.1674-0785.2024.12.008

Abstract

Abstract:

Objective

To comprehensively investigate the awareness of and willingness to use digital therapeutics (DTx) among orthopedic rehabilitation medical staff, analyze the possible problems in its use, and provide decision-making basis for the development and application of DTx.

Methods

An observational cross-sectional study was used to investigate the awareness of and willingness to use DTx among orthopedic rehabilitation medical staff in four public medical institutions in Beijing via a questionnaire survey, and the results were statistically analyzed.

Results

A total of 381 valid questionnaires were collected, and it was found through statistical analysis that orthopedic rehabilitation medical staff had a relatively low level of awareness of DTx, and there were differences in the level of awareness among orthopedic rehabilitation medical staff with different positions. Orthopaedic rehabilitation therapists were more aware of DTx than orthopaedic nurses and physicians. Most medical staff were optimistic about DTx,and they believed that DTx could improve work efficiency and provide more convenient and flexible health management methods for patients, and were willing to use DTx to manage patients. However, only 21% of participants had used DTx. In addition, 60.89% of participants were concerned about privacy and security issues, 43.83% were concerned about weakening interpersonal relationships with patients, 46.72% were concerned about taking up free time, and only 41.99% were willing to spend more than 30 minutes per day on DTx.

Conclusion

Although most orthopedic rehabilitation medical staff had low awareness and utilization of DTx, and there were differences in the level of awareness of DTx among orthopedic rehabilitation medical staff with different positions, they expressed their support and willingness to try the new rehabilitation mode of orthopedic rehabilitation DTx. Therefore, targeted training and promotion for medical staff with different positions may help to improve their awareness and usage of DTx.

Key words: Orthopedic rehabilitation, Digital therapeutics, Questionnaire

Fangming Liu, Chong Tang, Keshi Zhang, Xiuxiu Shi, Jiedan Mu, Guishan Wang, Zhenpeng Guan, Xiao Li. Awareness of and willingness to use digital therapeutics among orthopedic rehabilitation medical staff: a questionnaire survey[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(12): 1125-1131.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2024.12.008

https://zhlcyszz.cma-cmc.com.cn/EN/Y2024/V18/I12/1125

Figures/Tables 6

References 33

1	霍家康, 郭欣, 戴婉薇, 等. 我国康复需求与科研供给关系的回顾性研究 [J]. 中国科学:生命科学, 2023, 53(9): 1287-1297.
2	王一然, 戴婉薇, 苏彬彬, 等. 我国康复服务需求评估与供需缺口原因分析 [J]. 中国康复理论与实践, 2022, 28(6): 725-729.
3	Phan P, Mitragotri S, Zhao Z. Digital therapeutics in the clinic [J].Bioeng Transl Med, 2023, 8(4): e10536.
4	Hong JS, Wasden C, Han DH. Introduction of digital therapeutics [J].Comput Methods Programs Biomed, 2021, 209: 106319.
5	Son S, Yoo BR, Jeong YM. Digital therapeutics-based lumbar core exercise for patients with low back pain: A prospective exploratory pilot study [J]. Digit Health, 2024, 10: 20552076231218154.
6	Orsolini L, Longo G, Volpe U. Practical application of digital therapeutics in people with mood disorders [J]. Curr Opin Psychiatry,2024, 37(1): 9-17.
7	Kario K, Nomura A, Harada N, et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial [J]. Eur Heart J, 2021, 42(40): 4111-4122.
8	Saleh ZM, Chey WD, Berry SK. Behavioral health digital therapeutics for patients with irritable bowel syndrome: a primer for gastroenterologists [J]. Am J Gastroenterol, 2023, 118(8): 1311-1313.
9	Rumi G, Canonica GW, Foster JM, et al. Digital coaching using smart inhaler technology to improve asthma management in patients with asthma in Italy: community-based study [J]. JMIR Mhealth Uhealth,2022, 10(11): e25879.
10	Fundoiano-Hershcovitz Y, Feniger E, Dar S, et al. Digital therapeutics for type 2 diabetes: incorporating coaching support and validating digital monitoring [J]. J Diabetes Sci Technol, 2021, 15(5): 1188-1189.
11	Rohaj A, Bulaj G. Digital Therapeutics (DTx) expand multimodal treatment options for chronic low back pain: the nexus of precision medicine, patient education, and public health [J]. Healthcare (Basel),2023, 11(10): 1469.
12	Correia FD, Molinos M, Luís S, et al. Digitally assisted versus conventional home-based rehabilitation after arthroscopic rotator cuffrepair: a randomized controlled trial [J]. Am J Phys Med Rehabil,2022, 101(3): 237-249.
13	Shah N, Costello K, Mehta A, et al. Applications of digital health technologies in knee osteoarthritis: narrative review [J]. JMIR Rehabil Assist Technol, 2022, 9(2): e33489.
14	Rassi-Cruz M, Valente F, Caniza MV. Digital therapeutics and the need for regulation: how to develop products that are innovative, patientcentric and safe [J]. Diabetol Metab Syndr, 2022, 14(1): 48.
15	刘芳明, 石秀秀, 唐冲, 等. 骨科康复患者对数字疗法应用的知晓度和需求度：一项基于928 份问卷调查结果分析 [J/OL]. 中华临床医师杂志(电子版), 2024, 18(7): 654-661.
16	Brezing CA, Brixner DI. The rise of prescription digital therapeutics in behavioral health [J]. Adv Ther, 2022, 39(12): 5301-5306.
17	Budney AJ, Marsch LA, Aklin WM, et al. Workshop on the development and evaluation of digital therapeutics for health behavior change: science, methods, and projects [J]. JMIR Ment Health, 2020,7(2): e16751.
18	Basch E. Digital therapeutics for remote symptom monitoring and management in cancer care: the current and future state [J]. Ann Oncol, 2023, 34(8): 635-637.
19	Bickenbach J, Sabariego C, Stucki G. Beneficiaries of rehabilitation [J].Arch Phys Med Rehabil, 2021, 102(3): 543-548.
20	Bates B. Doctor and nurse: changing roles and relations [J]. N Engl J Med, 1970, 283(3): 129-134.
21	Liu J, Liu S, Zheng T, et al. Physicians' perspectives of telemedicine during the COVID-19 pandemic in China: qualitative survey study [J].JMIR Med Inform, 2021, 9(6): e26463.
22	Li Y, Gong Y, Zheng B, et al. Effects on adherence to a mobile appbased self-management digital therapeutics among patients with coronary heart disease: pilot randomized controlled trial [J]. JMIR Mhealth Uhealth, 2022, 10(2): e32251.
23	Kollins SH, DeLoss DJ, Cañadas E, et al. A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD):a randomised controlled trial [J]. Lancet Digit Health, 2020, 2(4):e168-e178.
24	Nomura A, Tanigawa T, Kario K, et al. Cost-effectiveness of digital therapeutics for essential hypertension [J]. Hypertens Res, 2022,45(10): 1538-1548.
25	Müthing J, Jäschke T, Friedrich CM. Client-focused security assessment of mHealth apps and recommended practices to prevent or mitigate transport security issues [J]. JMIR Mhealth Uhealth, 2017,5(10): e147.
26	Schnall R, Higgins T, Brown W, et al. Trust, perceived risk, perceived ease of use and perceived usefulness as factors related to mHealth technology use [J]. Stud Health Technol Inform, 2015, 216: 467-471.
27	Larentzakis A, Lygeros N. Artificial intelligence (AI) in medicine as a strategic valuable tool [J]. Pan Afr Med J, 2021, 38: 184.
28	Mueller FB. AI (Artificial Intelligence) and hypertension research [J].Curr Hypertens Rep, 2020, 22(9): 70.
29	He J, Baxter SL, Xu J, et al. The practical implementation of artificial intelligence technologies in medicine [J]. Nat Med, 2019, 25(1): 30-36.
30	Nadarzynski T, Miles O, Cowie A, et al. Acceptability of artificial intelligence (AI)-led chatbot services in healthcare: A mixed-methods study [J]. Digit Health, 2019, 5: 2055207619871808.
31	Maadi M, Akbarzadeh Khorshidi H, Aickelin U. A review on human-AI interaction in machine learning and insights for medical applications [J]. Int J Environ Res Public Health, 2021, 18(4): 2121.
32	Palanica A, Flaschner P, Thommandram A, et al. Physicians'perceptions of chatbots in health care: cross-sectional web-based survey [J]. J Med Internet Res, 2019, 21(4): e12887.
33	De Rosis S, Barsanti S. Patient satisfaction, e-health and the evolution of the patient-general practitioner relationship: evidence from an Italian survey [J]. Health Policy, 2016, 120(11): 1279-1292.

项目	[ 例（%）]
性别
男性	144（37.8）
女性	237（62.2）
年龄
30 岁以下	208（54.59）
31～40 岁	98（25.72）
41～50 岁	65（17.06）
50 岁以上	10（2.62）
学历
专科及以下	55（14.44）
本科	217（56.69）
硕士	74（19.42）
博士	35（9.19）
岗位
医生	118（30.97）
护士	97（25.46）
治疗师	151（39.63）
研究员	15（3.94）
工作年限
实习	14（3.67）
0～5 年	152（39.9）
6～10 年	85（22.31）
10～15 年	58（15.22）
16～20 年	55（14.44）
21～25 年	7（1.84）
25 年以上	10（2.62）

项目	[ 例（%）]
性别
男性	144（37.8）
女性	237（62.2）
年龄
30 岁以下	208（54.59）
31～40 岁	98（25.72）
41～50 岁	65（17.06）
50 岁以上	10（2.62）
学历
专科及以下	55（14.44）
本科	217（56.69）
硕士	74（19.42）
博士	35（9.19）
岗位
医生	118（30.97）
护士	97（25.46）
治疗师	151（39.63）
研究员	15（3.94）
工作年限
实习	14（3.67）
0～5 年	152（39.9）
6～10 年	85（22.31）
10～15 年	58（15.22）
16～20 年	55（14.44）
21～25 年	7（1.84）
25 年以上	10（2.62）

	完全不了解	听说过不了解	有点了解	比较了解	非常了解
医生	51（43.22）	44（37.29）	16（13.56）	4（3.39）	3（2.54）
护士	32（32.99）	45（46.39）	14（14.43）	5（5.15）	1（1.03）
治疗师	31（20.53）	76（50.33）	36（23.84）	6（3.97）	2（1.32）
研究员	4（26.67）	4（26.67）	4（26.67）	3（20）	0（0）
总计	118（30.97）	169（44.36）	70（18.37）	18（4.72）	6（1.57）

	完全不了解	听说过不了解	有点了解	比较了解	非常了解
医生	51（43.22）	44（37.29）	16（13.56）	4（3.39）	3（2.54）
护士	32（32.99）	45（46.39）	14（14.43）	5（5.15）	1（1.03）
治疗师	31（20.53）	76（50.33）	36（23.84）	6（3.97）	2（1.32）
研究员	4（26.67）	4（26.67）	4（26.67）	3（20）	0（0）
总计	118（30.97）	169（44.36）	70（18.37）	18（4.72）	6（1.57）

条目	是	否
是否使用过数字疗法管理患者健康？	80（21）	201（79）
是否愿意使用数字疗法管理患者健康？	286（75.07）	95（24.93）
认为数字疗法可以更方便灵活地管理患者健康？	306（80.31）	75（19.69）
认为数字疗法可以提升自身工作效率？	312（81.89）	69（18.11）
是否愿意患者接受数字疗法提供的康复指导？	330（86.61）	51（13.39）

Please choose a citation manager

Content to export